NCT03747276

Brief Summary

The proposed study will include patients with non-haematologic cancer. Eligible patients will be invited to consent for participation in our study using standard demographic data collection forms and patient satisfaction questionnaires. Cancer patients interested in learning more about clinical trials would be invited to go to the kiosk. A summer student approved and hired according to London Health Sciences Centre LHSC/Lawson criteria will be available from 0900-1630 daily for general assistance. If the student is overwhelmed by questions or numbers of patients, the Research Navigator or designate would be called to assist. An information kiosk will be placed at the patient library on the ground floor of the LRCP. This kiosk will be outfitted with a computer and signage briefly outlining the title and purpose of the kiosk. Cancer patients interested in learning more about clinical trials would be invited to participate in our study by signing a consent form allowing the Research Navigator to contact them if they expressed interest in knowing more about a clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

July 19, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 20, 2018

Completed
Last Updated

May 20, 2022

Status Verified

November 1, 2018

Enrollment Period

2 months

First QC Date

June 13, 2018

Last Update Submit

May 16, 2022

Conditions

Keywords

clinical trialaccrual

Outcome Measures

Primary Outcomes (1)

  • Change in accrual rate

    Our primary objective is to quantify the clinical trial accrual rates in a subset of trials that are selected as priority trials and are open both two months before and three months after implementation of the clinical trial information kiosk. Accrual rates before and after implementation will be compared.

    4 months (A two month rate of accrual (May-June, 2018) will be determined before opening the kiosk. A second two month accrual period (August-September) will be used to assess the change in trial accrual.

Secondary Outcomes (5)

  • Proportion of patients requesting research navigator contact

    3 months

  • Proportion of patients contacted eligible for clinical trial

    3 months

  • Proportion of eligible patients participating in clinical trial

    5 months

  • Satisfaction with kiosk

    2 months

  • Proportion of patients accessing kiosk

    2 months

Other Outcomes (1)

  • Demographics

    2 months

Study Arms (1)

Clinical Trial Kiosk

OTHER
Other: Clinical Trial Kiosk

Interventions

Kiosk will consist of a patient facilitator and a computer with access to general information about clinical trials and information specific to active clinical trials at the facility. Patients will be made aware of the kiosk via a large banner visible in the clinic above the kiosk.

Clinical Trial Kiosk

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients diagnosed with a solid tumour cancer (including breast, central nervous system, gynecologic, gastrointestinal, genitourinary, head and neck, liver, melanoma, neuroendocrine, sarcoma, thoracic, thyroid).
  • Patients able to provide independent informed consent.

You may not qualify if:

  • Patients less than 18 years of age
  • Patients diagnosed with haematologic malignancy unless there is a co-existing solid tumour cancer
  • Inability to provide informed consent
  • Inability to read and comprehend written English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6A 4G5, Canada

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2018

First Posted

November 20, 2018

Study Start

July 19, 2018

Primary Completion

September 18, 2018

Study Completion

November 18, 2018

Last Updated

May 20, 2022

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will share

Present at meetings and publish in peer reviewed journal

Shared Documents
STUDY PROTOCOL
Time Frame
One year

Locations